BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28893524)

  • 1. [Hippocampus, brainstem and brain dose-volume constraints for fractionated 3-D radiotherapy and for stereotactic radiation therapy: Limits and perspectives].
    Gérard M; Jumeau R; Pichon B; Biau J; Blais E; Horion J; Noël G
    Cancer Radiother; 2017 Oct; 21(6-7):636-647. PubMed ID: 28893524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.
    Milano MT; Grimm J; Niemierko A; Soltys SG; Moiseenko V; Redmond KJ; Yorke E; Sahgal A; Xue J; Mahadevan A; Muacevic A; Marks LB; Kleinberg LR
    Int J Radiat Oncol Biol Phys; 2021 May; 110(1):68-86. PubMed ID: 32921513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Lung dose constraints for normo-fractionated radiotherapy and for stereotactic body radiation therapy].
    Blais E; Pichon B; Mampuya A; Antoine M; Lagarde P; Kantor G; Breton-Callu C; Lefebvre C; Gerard M; Aamarcha A; Ozsahin M; Bourhis J; Maingon P; Troussier I; Pourel N
    Cancer Radiother; 2017 Oct; 21(6-7):584-596. PubMed ID: 28886981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing the Therapeutic Ratio of Stereotactic Ablative Radiotherapy by Individualized Isotoxic Dose Prescription.
    Zindler JD; Thomas CR; Hahn SM; Hoffmann AL; Troost EG; Lambin P
    J Natl Cancer Inst; 2016 Feb; 108(2):. PubMed ID: 26476075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dose constraints to organs at risk for conformational and stereotactic radiotherapy: Small bowel and duodenum].
    Goupy F; Chajon E; Castelli J; Le Prisé É; Duvergé L; Jaksic N; Vogin G; Monpetit É; Klein V; de Bosschère L; Maingon P
    Cancer Radiother; 2017 Oct; 21(6-7):613-618. PubMed ID: 28886980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Doses to organs at risk in conformational and stereotactic body radiation therapy: Liver].
    Debbi K; Janoray G; Scher N; Deutsch É; Mornex F
    Cancer Radiother; 2017 Oct; 21(6-7):604-612. PubMed ID: 28893525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Limits of dose constraint definition for organs at risk specific to stereotactic radiotherapy].
    Beddok A; Loi M; Rivin Del Campo E; Dumas JL; Orthuon A; Créhange G; Huguet F
    Cancer Radiother; 2023 Jun; 27(4):341-348. PubMed ID: 37208260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous integrated protection : A new concept for high-precision radiation therapy.
    Brunner TB; Nestle U; Adebahr S; Gkika E; Wiehle R; Baltas D; Grosu AL
    Strahlenther Onkol; 2016 Dec; 192(12):886-894. PubMed ID: 27757502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Doses to organs at risk for conformational and stereotactic radiotherapy: Bladder].
    Duvergé L; Castelli J; Lizée T; de Crevoisier R; Azria D
    Cancer Radiother; 2017 Oct; 21(6-7):597-603. PubMed ID: 28882511
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Delineation of organs at risk and dose constraints].
    Noël G; Antoni D; Barillot I; Chauvet B
    Cancer Radiother; 2016 Sep; 20 Suppl():S36-60. PubMed ID: 27516050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radionecrosis following stereotactic radiotherapy of a 3-cm brain metastasis: Can we improve the dosimetric results?].
    Brun L; Dupic G; Chassin V; Verrelle P; Lapeyre M; Biau J
    Cancer Radiother; 2018 Sep; 22(5):423-428. PubMed ID: 30078613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hippocampal sparing in stereotactic radiotherapy for brain metastases: To contour or not contour the hippocampus?
    Di Carlo C; Trignani M; Caravatta L; Vinciguerra A; Augurio A; Perrotti F; Di Tommaso M; Nuzzo M; Giancaterino S; Falco MD; Genovesi D
    Cancer Radiother; 2018 Apr; 22(2):120-125. PubMed ID: 29576492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological implications of whole-brain radiotherapy versus stereotactic radiosurgery of multiple brain metastases.
    Xue J; Kubicek GJ; Grimm J; LaCouture T; Chen Y; Goldman HW; Yorke E
    J Neurosurg; 2014 Dec; 121 Suppl():60-8. PubMed ID: 25434938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dose Gradient Index for Stereotactic Radiosurgery/Radiation Therapy.
    Reynolds TA; Jensen AR; Bellairs EE; Ozer M
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):604-611. PubMed ID: 32014151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-coplanar volumetric-modulated arc therapy (VMAT) for craniopharyngiomas reduces radiation doses to the bilateral hippocampus: a planning study comparing dynamic conformal arc therapy, coplanar VMAT, and non-coplanar VMAT.
    Uto M; Mizowaki T; Ogura K; Hiraoka M
    Radiat Oncol; 2016 Jun; 11():86. PubMed ID: 27338798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cervicothoracic region stereotactic spine radiosurgery on adjacent organs at risk.
    Sharma M; Bennett EE; Rahmathulla G; Chao ST; Koech HK; Gregory SN; Emch T; Magnelli A; Meola A; Suh JH; Angelov L
    Neurosurg Focus; 2017 Jan; 42(1):E14. PubMed ID: 28041323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose-Response Modeling of the Visual Pathway Tolerance to Single-Fraction and Hypofractionated Stereotactic Radiosurgery.
    Hiniker SM; Modlin LA; Choi CY; Atalar B; Seiger K; Binkley MS; Harris JP; Liao YJ; Fischbein N; Wang L; Ho A; Lo A; Chang SD; Harsh GR; Gibbs IC; Hancock SL; Li G; Adler JR; Soltys SG
    Semin Radiat Oncol; 2016 Apr; 26(2):97-104. PubMed ID: 27000505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Radiotherapy for brain metastases].
    Latorzeff I; Antoni D; Gaudaire-Josset S; Feuvret L; Tallet-Richard A; Truc G; Noël G
    Cancer Radiother; 2016 Sep; 20 Suppl():S80-7. PubMed ID: 27523410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hepatic tumors and radiotherapy].
    Rio E; Mornex F; Peiffert D; Huertas A
    Cancer Radiother; 2016 Sep; 20 Suppl():S174-8. PubMed ID: 27521035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.